|
|
181 Cheshire Lane Suite 100 Plymouth, MN 55441 USA phone:763-225-6699 fax:
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
10 |
|
|
| www.interradmedical.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Medical devices for use in minimally Invasive interventional and surgical procedures
|
 |
| Management |
| Jeff Killion, Vice President and Chief Marketing Officer; Sew-Wah Tay, PhD, Vice President Regulatory and Clinical (Contract); Michael Rosenberg, MD, Chief Medical Officer (Contract); Travis Murphy, CPA, Chief Financial Officer (Contract) |
|
|
| |
| Keywords |
| imaging, interventional radiology, SecurAcath, PICC line, CVC, dialysis, jp drain, catheter
|
|
|
|
|
|
| Description |
|
Development and commercialization of innovative medical devices for use in minimally invasive interventional and surgical procedures.
|
 |
| Products / Services |
Interrad Medical's first product is the SecurAcath Subcutaneous Catheter Securement System, a new and unique method for holding indwelling catheters in place without stitches or surgery.
|
 |
| Technology / Differentiation |
| The SecurAcath System utilizes a very small anchor that deploys just under the skin to hold a catheter securely in place. This technique has the potential to become the new standard method for securing all indwelling catheters, including PICC lines, CVCs, dialysis catheters, and drainage tubes.
|
 |
| Market / Customers |
Interrad Medical's current portfolio contains three devices and represents a worldwide market opportunity of over $2 billion.
|
 |
| Status |
| The SecurAcath System is currently pending FDA 510k clearance. |
 |
|
|
|
|